September 25, 2008 - Boston Scientific Corp. announced it has received approval from the FDA to market its TAXUS Express2 Atom paclitaxel-eluting coronary stent system, a drug-eluting stent (DES) specifically designed for treating small coronary vessels.

The TAXUS Express2 Atom Stent System is the only DES approved by the FDA for use in vessels as small as 2.25 mm in diameter, stated Boston Scientific.

September 25, 2008 - The Global Markets for Cardiac Rhythm Management (CRM) Devices 2009 report by Millennium Research Group (MRG) shows the CRM device market has recovered after a slump caused by several device recalls that began in 2005, and that the market will continue its recovery and growth over the next five years due largely to implantable defibrillator sales, which include implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).

September 25, 2008- The use of the CVRx Rheos System in treating early-stage heart failure patients shows Rheos Therapy significantly improved heart structure and function, according to clinical data presented this week by John D. Bisognano, M.D, Ph.D., associate professor of medicine at the University of Rochester School of Medicine and Dentistry, New York, at the Heart Failure Society of America (HFSA) 12th Annual Scientific Meeting in Toronto.

September 23, 2008 – In response to the FDA approval of Covidien’s ANDA for generic Kit for the Preparation of Technetium Tc99m Sestamibi Injection, Lantheus Medical Imaging said it will compete with competitive pricing.

September 24, 2008 - Philips Research and the University of Urbino (Urbino, Italy) this week signed a research agreement to study the encapsulation of magnetic nanoparticle contrast agents inside living blood cells to prolong the retention time of these agents in the blood.

September 24, 2008 - GE Healthcare’s satisfaction scores reflect significant improvements in customer perceptions of service quality in both MD Buyline’s second quarter 2008 customer satisfaction survey and IMV ServiceTrak’s 2008 report.

MD Buyline and ServiceTrak present independent analysis of service trends in industry and manufacturer ratings within each modality.

September 24, 2008 - Bracco Diagnostics Inc. and Lantheus Medical Imaging Inc. said yesterday they entered into an agreement for Lantheus to co-promote Bracco’s CardioGen-82 (Rubidium Rb 82 Generator), a myocardial perfusion positron emission tomography (PET) imaging agent.

CardioGen-82 is the only generator-based PET perfusion agent approved by the FDA and reimbursed for the evaluation of coronary artery disease (CAD).

September 23, 2008 - The 2008 Frost & Sullivan European Product Innovation Award in the field of novel real-time image reconstruction products has been presented to Barco.

The Belgium-based company leads in the provision of high-quality display and image processing solutions with its three-dimensional reconstruction product, TDRS-7101.

The Frost & Sullivan Award for Product Innovation is presented each year to the company that has demonstrated excellence in new products and technologies within its industry.

September 23, 2008 – The FDA has granted approval for Covidien’s generic kit for the preparation of technetium Tc99m Sestamibi injection use for nuclear myocardial perfusion imaging.

September 23, 2008 - New analysis from the largest outpatient study of heart failure patients in the U.S. shows they are receiving inconsistent care, according to the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF), sponsored by Medtronic, Inc.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now